出品|远见资本局作者|远见君3月26日,巨子生物发布了2024年度业绩公告。财报显示,巨子生物报告期内实现营收55.39亿元,同比增长57.2%;实现归属净利润20.62亿元,同比增长42.1%。公司毛利率高达82.09%,净利率为37.22%。分产品类别来看,2024年巨子生物功效性护肤品总收入为43.02亿元,占营收的比重从上年的75.1%提升至77.7%,医用敷料业务收入为12.18亿元,占...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.